NeuroLaunch

NeuroLaunch is an accelerator based in Atlanta, Georgia, focused on supporting early-stage startups in the neuroscience sector. Established in 2014, the company specializes in providing seed and growth funding to ventures involved in areas such as neuro-gaming, neuroplasticity, brain-computer interfacing, neuroinformatics, neuro-imaging, and medical technologies, including pharmaceuticals and diagnostics. NeuroLaunch invests between $20,000 and $100,000, typically seeking an equity stake of 2% to 7% depending on the development stage of the startup. The accelerator features a structured 90-day curriculum designed to prepare companies for follow-on funding, while also offering co-working space to foster collaboration among entrepreneurs. By nurturing innovative ideas and commercial applications emerging from neuroscience research, NeuroLaunch aims to cultivate a vibrant community of innovators, investors, and thought leaders in the field.

Christopher Klaus

Co-Founder and Investor

2 past transactions

Neurish

Pre Seed Round in 2020
Neurish, based in Atlanta, Georgia, operates a unique social network aimed at supporting individuals affected by epilepsy. The platform includes a mentorship program that connects patients and caregivers with those living well with the condition, facilitating the exchange of advice and support. Neurish offers three main applications: FriendsWithEpilepsy.com, a social networking site that enables users to create profiles, connect with others, and engage in group video chats; EpilepsyDocs.com, a web app that allows users to find, rate, and review local epilepsy doctors; and EpilepsyArticles.com, which aggregates the latest news and research on epilepsy into a single repository. By providing these resources, Neurish enhances the quality of life for patients and caregivers while addressing the challenges of finding reliable information and support in the epilepsy community.

QMENTA

Convertible Note in 2015
QMENTA is a software platform focused on imaging-based clinical studies, primarily aimed at enhancing the diagnosis and treatment of brain diseases. The company offers a cloud-based data management engine that integrates patented, AI-powered analytical algorithms alongside a marketplace of partnered algorithms. This platform allows healthcare professionals to compliantly collect, process, and analyze large-scale brain images and associated data efficiently. QMENTA's solutions encompass data management systems, clinical trials, neuroimaging disease packages, and neuro-data services, thereby facilitating improved medical imaging management and supporting clinical care and neuro research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.